Efficacy of the Social Cognition Rehabilitation Program E-motional Training in the Treatment of Patients With Substance-related Disorders
1 other identifier
interventional
231
1 country
2
Brief Summary
Drug use, substance use disorders (SUD) and other addictive behaviors are problems of enormous socio-health impact that still require a great research effort to improve the diagnostic and therapeutic procedures used in healthcare practice. Since addictive behaviors have been consistently associated with the presence of alterations in cognitive and executive functions, it is necessary to be able to detect, evaluate and have specific therapies for these dysfunctions and investigate, among other issues, the role they play in the onset and course evolutionary. After implementing neuropsychological evaluation techniques for diagnostic improvement, addresses the search for procedures that allow working on cognitive and executive deficits, as a specific therapeutic target. To characterize the presence of alterations in the domains that make up social cognition (SC) in patients with SUD and test in our healthcare units the ET® program already tested both experimentally and at beta level. It is an online self-training program for CS rehabilitation that includes modules for emotion recognition (RE), Theory of Mind (ToM) and attributional style (AS). To replicate the RCT carried out in schizophrenia in patients with SUD with difficulties in RE or ToM, in addition to searching for a biomarker or a pattern of them that predict the patient profile that will benefit from the training, using advanced LC-ESI proteomics techniques. MS/MS in saliva since previous studies in a population with schizophrenia, subjected to different neurorehabilitation therapies. It is also intended to subsequently improve the instrument (ET®) through the implementation of big data analysis and machine learning and the introduction of automated user management. At this level, the objective is to determine, after the first games, the type of game and the intensity required to improve the user's performance until it reaches normality. From the perspective of the State Plan for Scientific and Technical Research and Innovation, this project combines CLINICAL AND TRANSLATIONAL RESEARCH, based on the evidence of scientific and technological knowledge, and the use of ENABLING TECHNOLOGIES of e-health in the area of Health Services. Health for people with SUD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2022
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2023
CompletedFirst Submitted
Initial submission to the registry
January 31, 2024
CompletedFirst Posted
Study publicly available on registry
April 12, 2024
CompletedApril 12, 2024
February 1, 2024
9 months
January 31, 2024
April 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assess the presence of dysfunctions in the subdomains of social cognition
Social cognition by MASC test
up to 12 months
Secondary Outcomes (1)
Accuracy and efficacy of ET® in patients with SDB
up to 12 months
Study Arms (3)
Patients TRS without social cognition damage
NO INTERVENTIONPatients TRS without damage without intervention
Patients TRS with Social Cognition control
NO INTERVENTIONPatients TRS with social cognition damage with regular therapy in the centre
Patients TRS with social cognition with Emotional Training
EXPERIMENTALPatients TRS with social cognition damage with Emotional Training therapy in the centre
Interventions
Emotional Training Therapy following the programme in the computer
Eligibility Criteria
You may qualify if:
- Patients diagnosed with substance-related disorders (SUD) and other addictions according to DSM-5 diagnosed by an expert clinician.
- Have the capacity to consent (competence).
- Read the project information sheet and sign the informed consent.
- Age\>18 years-old
You may not qualify if:
- Illiterate
- Intellectual deficiency defined as IQ\<70,
- History of moderate or severe neurological pathology (TBI, stroke, etc.),
- Current acute psychiatric process
- Abstinence of less than 15 days,
- Advanced cognitive impairment that does not allow evaluation.
- Have participated in another similar study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Galicia Sur Health Research Institute (IISGS) - Hospital Álvaro Cunqueiro
Vigo, Pontevedra, 36213, Spain
Galicia Sur Health Research Institute
Vigo, Pontevedra, 36213, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 31, 2024
First Posted
April 12, 2024
Study Start
March 1, 2022
Primary Completion
December 1, 2022
Study Completion
December 30, 2023
Last Updated
April 12, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share